Award Notices

Heinz Lehmann Award

For Outstanding Contributions to Neuropsychopharmacology

Sponsored by Pfizer Canada Inc.

The Heinz Lehmann Award is designed to recognize outstanding contributions by a single individual in the field of research in neuropsychopharmacology in Canada. The Award consists of $2,000 honorarium and a suitably engraved plaque. The Heinz Lehmann Award shall be presented annually for work done primarily in Canada by Canadian scientists, unless there is, in the view of the Awards Committee, no qualified nominee.

Eligibility shall include individuals from academic institutions, foundations, governmental, industrial and research organizations, regardless of age or sex. The decision of the Awards Committee shall be based on originality and uniqueness of approach to clinical or laboratory research that had led to new, significant neuropsychopharmacological knowledge of concepts, or to the development of new therapeutic agents for the treatment of mental diseases. This should be evidenced by contributions based either on a specific piece of research or on a large body of neuropsychopharmacological research done over a period of years. The Awardee is expected to give a lecture based on his/her research at the Annual Meeting of the CCNP, and to contribute a manuscript based on the lecture to the CCNP official journal, the Journal of Psychiatry & Neuroscience, no later than six months after the lecture.

Nomination for 2018 Heinz Lehmann Award

The names of nominees should be received by Dr. Ridha Joober by November 30, 2017. Supporting documentation must be received by December 31, 2017. For each award, this documentation shall consist of:

  1. A completed Heinz Lehmann Award checklist, signed by the nominee.
  2. A two-page summary prepared by the sponsor describing the nominee’s work and its importance in furthering the field of neuropsychopharmacology.
  3. Up to 5 manuscripts or reprints considered by the sponsor to be pertinent to the nomination and which highlight the nominee’s work.
  4. The nominee's curriculum vitae.
  5. A brief biographical sketch of the candidate prepared by the sponsor.
Formal presentation of the Award will be made to the recipient during the Annual Meeting of the College.

Note: The Heinz Lehmann Research Award may be given for basic research or clinical research in alternate years. The 2018 Award will be presented for basic research.

Please send the name of the nominee and a short supporting letter to:

Dr. Ridha Joober
CCNP President

Please send one copy of the above electronically to Dr. Joober at ridha.joober@mcgill.ca and one copy to the CCNP Secretariat at rmena@ualberta.ca.

Deadline for receipt of initial nomination and short supporting letter is November 30, 2017.

See the previous recipients of awards.

Young Investigator Award

For Outstanding Contributions to Neuropsychopharmacology by a Young Investigator

Sponsored by Pfizer Canada Inc.

The Young Investigator Award is designed to recognize outstanding contributions in the field of research in neuropsychopharmacology by an individual young basic scientist or clinical investigator in Canada. Applications will be judged primarily on the basis of the candidate’s work as an independent investigator. The Award consists of a $2,000 honorarium and a suitably engraved plaque. The Young Investigator Award shall be presented annually for work done primarily in Canada by Canadian scientists, unless there is, in the view of the Awards Committee, no qualified nominee.

The major selection criterion is that the candidate be actively engaged in high quality neuropsychopharmacological research in Canada. There is no restriction concerning the field in which nominees have obtained their doctoral degree, but not more than ten years should have elapsed since the completion of their post-doctoral or residency training by July of the year of presentation. It is not required that the candidates be members of the College or have an academic appointment. The Awardee is expected to give a lecture based on his/her research at the Annual Meeting of the CCNP, and to contribute a manuscript based on the lecture to the CCNP official journal, the Journal of Psychiatry & Neuroscience, no later than six months after the lecture.

Nomination for 2018 CCNP Young Investigator Award

The names of nominees should be received by Dr. Ridha Joober by November 30, 2017. Supporting documentation must be received by December 31, 2017. For each award, this documentation shall consist of:

  1. A completed Young Investigator Award checklist, signed by the nominee.
  2. A two-page summary prepared by the sponsor describing the nominee’s work and its importance in furthering the field of neuropsychopharmacology.
  3. Up to 5 manuscripts or reprints considered by the sponsor to be pertinent to the nomination and which highlight the nominee’s work.
  4. The nominee's curriculum vitae.
  5. A brief biographical sketch of the candidate prepared by the sponsor.

Formal presentation of the Award will be made to the recipient during the Annual Meeting of the College.

Note: The Young Investigator Award is given for basic research or clinical research in alternate years. The 2017 Award will be presented for clinical research.

Please send the name of the nominee and a short supporting letter to:

Dr. Ridha Joober
CCNP President

Please send one copy of the above electronically to Dr. Joober at ridha.joober@mcgill.ca and one copy to the CCNP Secretariat at rmena@ualberta.ca.

Deadline for receipt of initial nomination and short supporting letter is November 30, 2017.

See the previous recipients of awards.

CCNP Innovations in Neuropsychopharmacology Research Award

For Outstanding Innovations in Neuropsychopharmacology by an Individual or Group

Sponsored by Pfizer Canada inc.

The Innovations in Neuropsychopharmacology Research Award is designed to recognize innovative research in neuropsychopharmacology. The Award consists of $2,000 and a suitably engraved plaque. The Innovations in Neuropsychopharmacology Award shall be presented annually for work done primarily in Canada by Canadian scientists, unless there is, in view of the Awards Committee, no qualified nominee.

The decision of the Awards Committee will be based solely on the outstanding innovative nature of the work by an individual or a group as demonstrated by a single piece of research contributed over a number of years. The Awardee(s) is/are expected to give a lecture based on his/her/their research at the Annual Meeting of the CCNP, and to contribute a manuscript, based on the lecture, to the CCNP official journal, the Journal of Psychiatry & Neuroscience, not later than six months after the lecture.

Nomination for 2018 Innovations in Neuropsychopharmacology Research Award

The names of nominees should be received by Dr. Ridha Joober by November 30, 2017. Supporting documentation must be received by December 31, 2017. For each award, this documentation shall consist of:

  1. A completed CCNP Innovations Award checklist, signed by the nominee.
  2. A two-page summary prepared by the sponsor describing the nominee’s work and its importance in furthering the field of neuropsychopharmacology.
  3. Up to 5 manuscripts or reprints considered by the sponsor to be pertinent to the nomination and which highlight the nominee’s work.
  4. The nominee's curriculum vitae.
  5. A brief biographical sketch of the candidate prepared by the sponsor.

Formal presentation of the Award will be made to the recipient during the Annual Meeting of the College.

Note: The Innovations in Neuropsychopharmacology Research Award may be given for basic research or clinical research in alternate years. The 2018 Award will be presented for basic research.

Please send the name of the nominee and a short supporting letter to:

Dr. Ridha Joober
CCNP President

Please send one copy of the above electronically to Dr. Joober at ridha.joober@mcgill.ca and one copy to the CCNP Secretariat at rmena@ualberta.ca.

Deadline for receipt of initial nomination and short supporting letter is November 30, 2017.

See the previous recipients of awards.

CCNP Medal

This Award was established to honour individuals for a meritorious career in, and outstanding contribution to, neuropsychopharmacology in Canada as evidenced by their activities in education, administration and/or patient care. Achievement in research is not a necessary criterion for this Award. An outstanding contribution implies achievement at the national or international level, and evidence of novel initiatives.

The Award, which does not have to be awarded each year, consists of a bronze medal engraved with the name of the recipient.

Nomination for 2018 CCNP Medal

The names of nominees should be received by Dr. Ridha Joober by November 30, 2017. Supporting documentation must be received by December 31, 2017. For each award, this documentation shall consist of:

  1. A completed CCNP Medal checklist, signed by the nominee.
  2. A two-page summary prepared by the sponsor describing the nominee’s work and its importance in furthering the field of neuropsychopharmacology.
  3. The nominee's curriculum vitae and list of publications.
  4. A brief biographical sketch of the candidate prepared by the sponsor.

Formal presentation of the Award will be made to the recipient during the Annual Meeting of the College.

Please send the name of the nominee and a short supporting letter to:

Dr. Ridha Joober
CCNP President

Please send one copy of the above electronically to Dr. Joober at ridha.joober@mcgill.ca and one copy to the CCNP Secretariat at rmena@ualberta.ca.

Deadline for receipt of initial nomination and short supporting letter is November 30, 2017.

See the previous recipients of awards.

Jock Cleghorn Prize

This prize, which will consist of a cheque for $500, will be awarded by the CCNP for the best poster presentation by a research trainee (graduate student or clinical resident or postdoc) at the Annual Meeting of the CCNP. All trainees/students who submit a poster presentation for the Annual Meeting will be eligible for this prize. Those already applying for travel bursaries will automatically be considered for the Jock Cleghorn Prize.

The poster presentations will be judged at the Annual Meeting by a committee consisting of at least 3 members of the CCNP council (or substitute judges to be chosen by the Council from the CCNP membership if needed). Topics on either basic or clinical aspects of neuropsychopharmacology will be considered. The poster should represent research in which the graduate student, postdoc, or resident is the primary investigator. Only the first author of the submitted abstract is eligible for the award. The winner of the award will be announced at the CCNP banquet and in the first Newsletter following the Annual Meeting.